Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What Could Keep the FDA From Green Lighting Pfizer's and Moderna's Vaccines?

TheMotleyFool

0 0

What Could Keep the FDA From Green Lighting Pfizer's and Moderna's Vaccines?

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) await critical FDA advisory committee reviews for their respective COVID-19 vaccine candidates over the next two weeks. The prospects that both vaccines win Emergency Use Authorization (EUA) from the FDA following those reviews appear to be pretty good. However, it's not a total slam dunk. In this Motley Fool Live video recorded on Dec. 3, 2020, healthcare and cannabis bureau chief Corinne Cardina and Fool.com writer Keith Speights discuss what could keep Pfizer's and Moderna's COVID vaccines from EUA.

Source Fool.com

Like: 0

PFE

Share